当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Stephen Bondy
New drug therapies for Alzheimer's disease (AD) are currently in late clinical development. Once approved, new healthcare infrastructure and services, including primary health care, will be required to meet the great demand for early and large-scale detection of AD. The need for assessment in this area was of great concern to adults. Early detection of cognitive impairment is further advanced by new technologies in the future. Identifying evidence is one of the most important steps in diagnosis to ensure that the correct diagnosis and procedure is needed. This review noted several different methods of cognitive impairment and early detection in the elderly, and the importance of having a positive attitude towards the family during discovery.